Challenges in lung cancer therapy during the COVID-19 pandemic

by Calabrò, Luana, Peters, Solange, Soria, Jean-Charles, Di Giacomo, Anna Maria, Barlesi, Fabrice, Covre, Alessia, Altomonte, Maresa, Vegni, Virginia, Gridelli, Cesare, Reck, Martin, Rizvi, Naiyer, Maio, Michele
Published in Lancet Respir Med (2020)

Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients

by Maccalli, Cristina, Giannarelli, Diana, Chiarucci, Carla, Cutaia, Ornella, Giacobini, Gianluca, Hendrickx, Wouter, Amato, Giovanni, Annesi, Diego, Bedognetti, Davide, Altomonte, Maresa, Danielli, Riccardo, Calabrò, Luana, Di Giacomo, Anna Maria, Marincola, Francesco M., Parmiani, Giorgio, Maio, Michele
Published in Oncoimmunology (2017)

Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme

by Altomonte, Maresa, Di Giacomo, Anna Maria, Queirolo, Paola, Ascierto, Paolo Antonio, Spagnolo, Francesco, Bajetta, Emilio, Calabrò, Luana, Danielli, Riccardo, de Rosa, Francesco, Maur, Michela, Chiarion-Sileni, Vanna, Ferrucci, Pier Francesco, Giannarelli, Diana, Testori, Alessandro, Ridolfi, Ruggero, Maio, Michele
Published 2013

Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort

by Ascierto, Paolo A, Simeone, Ester, Sileni, Vanna Chiarion, Pigozzo, Jacopo, Maio, Michele, Altomonte, Maresa, Del Vecchio, Michele, Di Guardo, Lorenza, Marchetti, Paolo, Ridolfi, Ruggero, Cognetti, Francesco, Testori, Alessandro, Bernengo, Maria Grazia, Guida, Michele, Marconcini, Riccardo, Mandalà, Mario, Cimminiello, Carolina, Rinaldi, Gaetana, Aglietta, Massimo, Queirolo, Paola
Published 2014